ThinkSabio

$CGTX

$0.67▲ -2.9% YTD

5 SEC 13D/G filings tracked · Last updated Nov 9, 2026

Filing History
News
CGTX ▼ -2.9% - Cognition Therapeutics, Inc.
CP $0.67▲ -2.9%Nov 9, 2026 · ThinkSabio Blog

$CGTX - Cognition Therapeutics Invited to Participate in 2026 Jefferies Global Healthcare Conference…

News
CGTX ▲ +6.7% - Cognition Therapeutics, Inc.
CP $0.80▲ +6.7%Oct 22, 2026 · ThinkSabio Blog

$CGTX - Cognition Therapeutics Announces Alignment with FDA on Pivotal Phase 3 Trial of Zervimesine (CT1812) in Dementia with Lewy Bodies…

News
CGTX ▲ +2.4% - Cognition Therapeutics, Inc.
CP $0.87▲ +2.4%Oct 13, 2026 · ThinkSabio Blog

$CGTX - Cognition Therapeutics Announces Issuance of Composition of Matter Patent, Extending Protection for Zervimesine (CT1812) Through 2045…

News
CGTX ▲ +2.1% - Cognition Therapeutics, Inc.
CP $0.96▲ +2.1%Sep 29, 2026 · ThinkSabio Blog

$CGTX - Cognition Therapeutics Schedules a Type C Meeting with FDA to Align on Endpoints for Phase 3 Trial of Zervimesine (CT1812) in DLB…

News
CGTX ▲ +1.0% - Cognition Therapeutics, Inc.
CP $1.04▲ +1.0%Sep 8, 2026 · ThinkSabio Blog

$CGTX - Cognition Therapeutics to Present at H.C. Wainwright Global Investment Conference…